Hzymes Biotechnology
Wuhan
About Hzymes Biotechnology
Hzymes Biotechnology is a high-tech company that researches and develops core raw materials for the in vitro diagnostic industry. Hzymes manufactures high-quality enzymes on a large scale by incorporating five enzyme creation technology platforms. Hzymes recognizes the importance of global raw material supply security and is committed to improving human lives and health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $125.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2021)
- Website: hzymesbiotech.com
- Phone: +86 21 6087 9177
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/hzymes-biotechnology-46330 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.